{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Ischemic mitral regurgitation (IMR) presents a clinical challenge amidst evolving treatment paradigms, particularly when accompanied by coronary artery disease (CAD)."
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 1,
        "evidence": "Studies encompassing varied interventions, including coronary revascularization and concomitant mitral valve procedures, were scrutinized to gauge their impact on patient outcomes."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Harms": {
        "score": 1,
        "evidence": "However, the Cardiothoracic Surgical Trials Network (CTSN) trials raised concerns regarding adverse events and recurrence rates post-mitral repair."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 2,
    "max_score": 25
  },
  "model": "gpt-4o"
}